These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19200048)

  • 1. Targeting ERBB receptors to inhibit metastasis: old hopes and new certainties.
    Angelucci A
    Curr Cancer Drug Targets; 2009 Feb; 9(1):1-18. PubMed ID: 19200048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting ErbB receptors in high-grade glioma.
    Berezowska S; Schlegel J
    Curr Pharm Des; 2011; 17(23):2468-87. PubMed ID: 21827413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the betacellulin receptor in pancreatic AR42J cells.
    Ishiyama N; Kanzaki M; Seno M; Yamada H; Kobayashi I; Kojima I
    Diabetologia; 1998 Jun; 41(6):623-8. PubMed ID: 9662041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell biology of lymphatic metastasis. The potential role of c-erbB oncogene signalling.
    Eccles SA
    Recent Results Cancer Res; 2000; 157():41-54. PubMed ID: 10857161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-erbB-2 expression in primary gastric carcinomas and their metastases.
    David L; Seruca R; Nesland JM; Soares P; Sansonetty F; Holm R; Børresen AL; Sobrinho-Simões M
    Mod Pathol; 1992 Jul; 5(4):384-90. PubMed ID: 1353880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases.
    Lacroix H; Iglehart JD; Skinner MA; Kraus MH
    Oncogene; 1989 Feb; 4(2):145-51. PubMed ID: 2564657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs: mediators of ErbB family targeted therapy resistance.
    Adem BF; Bastos NR; Dias F; Teixeira AL; Medeiros R
    Pharmacogenomics; 2016 Jul; 17(10):1175-1187. PubMed ID: 27359187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ErbB receptors as prognostic and therapeutic drug targets in bone and soft tissue sarcomas.
    Wang H; Yang Q; Fu Z; Zuo D; Hua Y; Cai Z
    Cancer Invest; 2014 Dec; 32(10):533-42. PubMed ID: 25347730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells.
    Momeny M; Zarrinrad G; Moghaddaskho F; Poursheikhani A; Sankanian G; Zaghal A; Mirshahvaladi S; Esmaeili F; Eyvani H; Barghi F; Sabourinejad Z; Alishahi Z; Yousefi H; Ghasemi R; Dardaei L; Bashash D; Chahardouli B; Dehpour AR; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Sci Rep; 2017 Jun; 7(1):4204. PubMed ID: 28646172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MET receptor inhibition: Hope against resistance to targeted therapies?].
    Hochart A; Leblond P; Le Bourhis X; Meignan S; Tulasne D
    Bull Cancer; 2017 Feb; 104(2):157-166. PubMed ID: 27863726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
    Archer SG; Eliopoulos A; Spandidos D; Barnes D; Ellis IO; Blamey RW; Nicholson RI; Robertson JF
    Br J Cancer; 1995 Nov; 72(5):1259-66. PubMed ID: 7577479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy.
    Wei Q; Shui Y; Zheng S; Wester K; Nordgren H; Nygren P; Glimelius B; Carlsson J
    Oncol Rep; 2011 Jan; 25(1):3-11. PubMed ID: 21109951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Targeting epidermal growth factor receptor in cancer of the breast].
    Diéras V; Pierga JY; Vincent-Salomon A; Beuzeboc P; Pouillart P; de Cremoux P
    Bull Cancer; 2003 Nov; 90 Spec No():S257-62. PubMed ID: 14763149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.
    Yu D; Wang SS; Dulski KM; Tsai CM; Nicolson GL; Hung MC
    Cancer Res; 1994 Jun; 54(12):3260-6. PubMed ID: 7911396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
    Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
    Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
    Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.
    Abd El-Rehim DM; Pinder SE; Paish CE; Bell JA; Rampaul RS; Blamey RW; Robertson JF; Nicholson RI; Ellis IO
    Br J Cancer; 2004 Oct; 91(8):1532-42. PubMed ID: 15480434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer.
    Mizutani T; Onda M; Tokunaga A; Yamanaka N; Sugisaki Y
    Cancer; 1993 Oct; 72(7):2083-8. PubMed ID: 8397058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.